Synaptic Plasticity Pathway

Migration, Crosslink

📖

Synaptic Plasticity Pathway

active

wiki page Created: 2026-04-02T07:20:02 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-synaptic-plasticity

📖 Wiki Page

mechanism1549 wordssynced 2026-04-02

Synaptic Plasticity Pathway

Overview

Synaptic Plasticity Pathway plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Synaptic plasticity refers to the ability of synaptic connections to strengthen or weaken over time in response to activity patterns. This fundamental cellular mechanism underlies learning, memory, and cognitive function. In neurodegenerative diseases, synaptic dysfunction represents one of the earliest and most critical pathological features, often preceding neuronal loss by years or even decades. [@malenka2004]

The study of synaptic plasticity has revealed that synapses are not static structures but dynamic elements that continuously adapt their strength, structure, and molecular composition in response to neural activity, experience, and disease processes. [@selkoe2002]

Molecular Mechanisms of Synaptic Plasticity

Long-Term Potentiation (LTP)

[Long-term potentiation](/mechanisms/long-term-potentiation) is a persistent activity-dependent strengthening of synaptic connections that is widely considered the cellular basis for learning and memory. [LTP](/mechanisms/long-term-potentiation) occurs through several phases: [@henley2016]

...

Synaptic Plasticity Pathway

Overview

Synaptic Plasticity Pathway plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Synaptic plasticity refers to the ability of synaptic connections to strengthen or weaken over time in response to activity patterns. This fundamental cellular mechanism underlies learning, memory, and cognitive function. In neurodegenerative diseases, synaptic dysfunction represents one of the earliest and most critical pathological features, often preceding neuronal loss by years or even decades. [@malenka2004]

The study of synaptic plasticity has revealed that synapses are not static structures but dynamic elements that continuously adapt their strength, structure, and molecular composition in response to neural activity, experience, and disease processes. [@selkoe2002]

Molecular Mechanisms of Synaptic Plasticity

Long-Term Potentiation (LTP)

[Long-term potentiation](/mechanisms/long-term-potentiation) is a persistent activity-dependent strengthening of synaptic connections that is widely considered the cellular basis for learning and memory. [LTP](/mechanisms/long-term-potentiation) occurs through several phases: [@henley2016]

Early-Phase [LTP](/mechanisms/long-term-potentiation) (E-LTP) [@huganir2013]

Requires [NMDA receptor](/entities/nmda-receptor) activation and calcium influx into the postsynaptic neuron
Activation of CaMKII (Calcium/Calmodulin-dependent protein kinase II) which autophosphorylates and remains active
Insertion of additional AMPA receptors into the postsynaptic membrane
Phosphorylation of AMPA receptor subunits (GluA1 at Ser831 by CaMKII, Ser845 by PKA)
Transient increase in spine size

Late-Phase LTP (L-LTP) [@dumitriu2012]

Requires gene transcription and protein synthesis
Activation of CREB (cAMP response element-binding protein)
Synthesis of new proteins including AMPA receptor subunits, scaffolding proteins, and structural proteins
Growth of new synaptic contacts and stabilization of [dendritic spines](/cell-types/dendritic-spines)
Involves BDNF (Brain-Derived Neurotrophic Factor) signaling through TrkB receptors

Long-Term Depression (LTD)

Long-term depression is an activity-dependent weakening of synaptic strength that is essential for synaptic homeostasis and learning: [@calabresi2006]

NMDA Receptor-Dependent LTD [@schulzschaeffer2010]

Low-frequency stimulation (1 Hz for 15 minutes) leads to modest calcium influx
Activation of protein phosphatases including PP1 (protein phosphatase 1) and calcineurin
Dephosphorylation of AMPA receptor subunits
Internalization of AMPA receptors through clathrin-dependent endocytosis
Shrinking of [dendritic spines](/cell-types/dendritic-spines)

Metabotropic Glutamate Receptor (mGluR)-Dependent LTD [@hardy2002]

Activation of group I mGluRs (mGluR1/5)
Rapid synthesis of new proteins via [mTOR](/mechanisms/mtor-signaling-pathway-pathway) signaling
AMPA receptor internalization independent of NMDA receptor activity
Critical for certain forms of learning and memory

Structural Plasticity: Dendritic Spines

[Dendritic spines](/mechanisms/dendritic-spines) are small protrusions from dendrites that receive the majority of excitatory synaptic inputs. Their morphology is highly dynamic: [@mattson2004]

Thin spines: Highly plastic, unstable, often forming new synaptic connections
Stubby spines: Intermediate morphology
Mushroom spines: Large heads, stable synapses, higher synaptic strength
Filopodia: Protrusive structures that may form new connections

Spine dynamics are regulated by: [@kauer2007]

Actin cytoskeleton remodeling
Rho GTPases (Rac1, Cdc42, RhoA)
Spine-associated Rap GTPase (SPAR)
Ankyrin-G and related scaffolding proteins

Synaptic Plasticity in Alzheimer's Disease

Amyloid-Beta Effects on Synaptic Function

[Amyloid-beta](/proteins/amyloid-beta) (Aβ) peptides, the primary component of amyloid plaques in Alzheimer's disease, have profound effects on synaptic plasticity: [@citri2008]

Presynaptic Effects

Impairs vesicle release probability and recycling
Reduces synaptophysin and synapsin levels
Alters mitochondrial function at presynaptic terminals
Affects neurotransmitter release through nicotinic [acetylcholine](/entities/acetylcholine) receptors

Postsynaptic Effects

Blocks NMDA receptor-dependent LTP induction
Enhances NMDA receptor-dependent LTD
Reduces AMPA receptor trafficking to the synapse
Impairs CaMKII activation and autophosphorylation
Disrupts spine morphology and reduces spine density

Oligomeric Aβ as the Synaptotoxic Species

Soluble Aβ oligomers are more toxic than fibrils or monomers
Bind to prion protein (PrP^C) and perturb synaptic function
Activate Fyn kinase and NMDA receptor signaling
Induce mitochondrial dysfunction and oxidative stress

Tau Pathology and Synaptic Dysfunction

[Tau protein](/proteins/tau) pathology disrupts synaptic plasticity through multiple mechanisms:

Hyperphosphorylated tau mislocalizes from axons to dendrites
Tau in dendrites impairs AMPA receptor trafficking
tau oligomers directly impair synaptic function
Loss of tau from axons disrupts microtubule-based transport
tau pathology correlates with cognitive decline better than amyloid

Effects on Specific Plasticity Mechanisms

LTP Impairment

Aβ oligomers prevent LTP induction in hippocampal slices
Soluble Aβ correlates inversely with LTP in [APP](/entities/app-protein) transgenic mice
Anti-Aβ antibodies rescue LTP deficits

LTD Enhancement

Aβ lowers the threshold for LTD induction
Excessive LTD may contribute to synaptic loss
mGluR-LTD is particularly sensitive to Aβ

Structural Changes

Early loss of dendritic spines in hippocampal CA1 [neurons](/entities/neurons)
Spine loss correlates with cognitive impairment
Tau causes spine loss through dendritic mislocalization

Synaptic Plasticity in Parkinson's Disease

Dopaminergic Modulation of Synaptic Plasticity

The nigrostriatal dopamine system critically regulates synaptic plasticity in the basal ganglia:

D1 Receptor-Mediated Plasticity

D1 receptor activation promotes LTP in the striatum
Requires DARPP-32 and PKA signaling
Enhanced in early PD, may contribute to dyskinesias with levodopa

D2 Receptor-Mediated Plasticity

D2 receptor activation promotes LTD in the striatum
Involves adenosine A2A receptor crosstalk
Impaired in PD due to dopamine loss

Alpha-Synuclein Effects

[Alpha-synuclein](/proteins/alpha-synuclein) (αSyn) pathology directly impacts synaptic plasticity:

Presynaptic Effects

αSyn aggregates impair vesicle clustering and release
Affects synaptic vesicle docking and fusion machinery
Reduces dopamine release from striatal terminals
Leads to synaptic vesicle depletion

Synaptic Plasticity Dysregulation

αSyn oligomers impair LTP in hippocampal neurons
Affects NMDA receptor trafficking and function
Alters BDNF signaling and synaptic plasticity
Contributions to cognitive impairment in PD and DLB

Striatal Synaptic Plasticity

The dorsal striatum shows characteristic plasticity changes in PD:

Loss of dopamine-dependent LTP/LTD
Abnormal corticostriatal plasticity
Contributes to motor symptoms
Linked to levodopa-induced dyskinesias

Therapeutic Implications

Targeting Synaptic Plasticity for Treatment

Disease-Modifying Approaches

Anti-amyloid antibodies ([lecanemab](/entities/lecanemab), donanemab) may protect synapses
BACE inhibitors to reduce Aβ production (clinical trials)
Tau-targeted therapies to prevent tau-mediated dysfunction
Alpha-synuclein aggregation inhibitors

Symptomatic Treatments

Acetylcholinesterase inhibitors ([donepezil](/entities/donepezil), rivastigmine) enhance cholinergic signaling
NMDA receptor antagonists (memantine) modulate glutamatergic plasticity
Dopaminergic treatments restore striatal plasticity

Neurotrophic Factor Approaches

BDNF delivery to enhance synaptic plasticity
AAV-mediated GDNF expression
Small molecules that enhance neurotrophic signaling

Background

The study of Synaptic Plasticity Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Recent Research Updates (2024-2026)

Recent publications advancing opubmed.ncbi.nlm.nih.gov/38811309/)

[Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. (2024)](https://pubmed.ncbi.nlm.nih.gov/38303529/) — Curr Pharm Des PMID: 38303529(https://pubmed.ncbi.nlm.nih.gov/38303529/)

[A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. (2024)](https://pubmed.ncbi.nlm.nih.gov/39205389/) — Mol Ther PMID: 39205389(https://pubmed.ncbi.nlm.nih.gov/39205389/)

[Microglial lipid phosphatase SHIP1 limits complement-mediated synaptic pruning in the healthy developing hippocampus. (2025)](https://pubmed.ncbi.nlm.nih.gov/39657671/) — Immunity PMID: 39657671(https://pubmed.ncbi.nlm.nih.gov/39657671/)

[The potential therapeutic role of itaconate and mesaconate on the detrimental effects of LPS-induced neuroinflammation in the brain. (2024)](https://pubmed.ncbi.nlm.nih.gov/39164713/) — J Neuroinflammation PMID: 39164713(https://pubmed.ncbi.nlm.nih.gov/39164713/)

Confidence Assessment

🔴 Low Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 12 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |

Overall Confidence: 34%

Synaptic Plasticity Pathway

Mermaid diagram (expand to render)

References

[Bliss TV, Collingridge GL, A synaptic model of memory: long-term potentiation in the hippocampus (1993)](https://doi.org/10.1038/361031a0)

[Malenka RC, Bear MF, LTP and LTD: an embarrassment of riches (2004)](https://doi.org/10.1016/j.neuron.2004.09.012)

[Selkoe DJ, Alzheimer's disease is a synaptic failure (2002)](https://doi.org/10.1126/science.1074069)

[Henley JM, Wilkinson KA, Synaptic AMPA receptor composition in development, plasticity and disease (2016)](https://doi.org/10.1038/nrn.2016.37)

[Huganir RL, Nicoll RA, AMPARs and synaptic plasticity: the last 25 years (2013)](https://doi.org/10.1016/j.neuron.2013.10.025)

[Dumitriu D, Hyman BT, Spires-Jones TL, Synaptic alterations in Alzheimer's disease (2012)](https://doi.org/10.1016/j.brainres.2012.01.058)

[Calabresi P, Picconi B, Parnetti L, Di Filippo M, A convergent model for cognitive dysfunctions in Parkinson's disease (2006)](https://doi.org/10.1016/S1474-4422(06)

[Schulz-Schaeffer WJ, The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia (2010)](https://doi.org/10.1007/s00401-010-0711-0)

[Hardy J, Selkoe DJ, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics (2002)](https://doi.org/10.1126/science.1072994)

[Mattson MP, Pathways towards and away from Alzheimer's disease (2004)](https://doi.org/10.1038/nature02621)

[Kauer JA, Malenka RC, Synaptic plasticity and addiction (2007)](https://doi.org/10.1038/nrn2194)

[Citri A, Malenka RC, Synaptic plasticity: multiple forms, functions, and mechanisms (2008)](https://doi.org/10.1038/sj.npp.1301559)

Pathway Diagram

The following diagram shows the key molecular relationships involving Synaptic Plasticity Pathway discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

mechanisms-synaptic-plasticity

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-synaptic-plasticity
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-909e0fce0860
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-synaptic-plasticity'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

63

Outgoing

95

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Synaptic Plasticity Pathway

Synaptic Plasticity Pathway

Overview

Introduction

Molecular Mechanisms of Synaptic Plasticity

Long-Term Potentiation (LTP)

Synaptic Plasticity Pathway

Overview

Introduction

Molecular Mechanisms of Synaptic Plasticity

Long-Term Potentiation (LTP)

Long-Term Depression (LTD)

Structural Plasticity: Dendritic Spines

Synaptic Plasticity in Alzheimer's Disease

Amyloid-Beta Effects on Synaptic Function

Tau Pathology and Synaptic Dysfunction

Effects on Specific Plasticity Mechanisms

Synaptic Plasticity in Parkinson's Disease

Dopaminergic Modulation of Synaptic Plasticity

Alpha-Synuclein Effects

Striatal Synaptic Plasticity

Therapeutic Implications

Targeting Synaptic Plasticity for Treatment

Neurotrophic Factor Approaches

See Also

Background

External Links

See Also

Recent Research Updates (2024-2026)

Confidence Assessment

Synaptic Plasticity Pathway

References

Pathway Diagram

💬 Discussion